4/A

FORM 4/A SUBMISSION

Company: Finch Therapeutics Group, Inc.
Filed: June 23, 2023
Period of Report: June 9, 2023
Accession Number: 0000899243-23-016365

View Document ↗ View on SEC.gov ↗